Le Grand, Bruno,Junquero, Didier,Monjotin, Nicolas
申请号：
AU2014365665
公开号：
AU2014365665A1
申请日:
2014.10.31
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention relates to the use of PAR1 antagonists, in particular of vorapaxar, of atopaxar and of 3‑(2-chlorophenyl)-1-[4-(4-fluorobenzyl)piperazin-1-yl]propenone, or a pharmaceutically acceptable salt thereof, for preventing and/or treating pelvi-perineal functional pathological conditions, and more particularly painful bladder syndrome.
